These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34704622)

  • 21. Estimating optimal individualized treatment rules with multistate processes.
    Bakoyannis G
    Biometrics; 2023 Dec; 79(4):2830-2842. PubMed ID: 37015010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data.
    Bouvier F; Peyrot E; Balendran A; Ségalas C; Roberts I; Petit F; Porcher R
    Stat Med; 2024 May; 43(11):2043-2061. PubMed ID: 38472745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating individualized treatment rules with risk constraint.
    Huang X; Xu J
    Biometrics; 2020 Dec; 76(4):1310-1318. PubMed ID: 32002993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constructing treatment decision rules based on scalar and functional predictors when moderators of treatment effect are unknown.
    Ciarleglio A; Petkova E; Ogden T; Tarpey T
    J R Stat Soc Ser C Appl Stat; 2018 Nov; 67(5):1331-1356. PubMed ID: 30546161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LIBERTI: A SMART study in plastic surgery.
    Hibbard JC; Friedstat JS; Thomas SM; Edkins RE; Hultman CS; Kosorok MR
    Clin Trials; 2018 Jun; 15(3):286-293. PubMed ID: 29577741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selecting Optimal Subgroups for Treatment Using Many Covariates.
    VanderWeele TJ; Luedtke AR; van der Laan MJ; Kessler RC
    Epidemiology; 2019 May; 30(3):334-341. PubMed ID: 30789432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserving data privacy when using multi-site data to estimate individualized treatment rules.
    Danieli C; Moodie EEM
    Stat Med; 2022 Apr; 41(9):1627-1643. PubMed ID: 35088914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying predictive markers for personalized treatment selection.
    Shen Y; Cai T
    Biometrics; 2016 Dec; 72(4):1017-1025. PubMed ID: 26999054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling variability in treatment effects for cluster randomized controlled trials using by-variable smooth functions in a generalized additive mixed model.
    Cho SJ; Preacher KJ; Yaremych HE; Naveiras M; Fuchs D; Fuchs LS
    Behav Res Methods; 2024 Mar; 56(3):2094-2113. PubMed ID: 37558925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying optimal biomarker combinations for treatment selection through randomized controlled trials.
    Huang Y
    Clin Trials; 2015 Aug; 12(4):348-56. PubMed ID: 25948620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable selection in high dimensions for discrete-outcome individualized treatment rules: Reducing severity of depression symptoms.
    Moodie EEM; Bian Z; Coulombe J; Lian Y; Yang AY; Shortreed SM
    Biostatistics; 2024 Jul; 25(3):633-647. PubMed ID: 37660312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A threshold-free summary index for quantifying the capacity of covariates to yield efficient treatment rules.
    Sadatsafavi M; Mansournia MA; Gustafson P
    Stat Med; 2020 Apr; 39(9):1362-1373. PubMed ID: 31998998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pool adjacent violators algorithm-assisted learning with application on estimating optimal individualized treatment regimes.
    Chen B; Yuan A; Qin J
    Biometrics; 2022 Dec; 78(4):1475-1488. PubMed ID: 34181761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting treatment-covariate interactions using permutation methods.
    Wang R; Schoenfeld DA; Hoeppner B; Evins AE
    Stat Med; 2015 May; 34(12):2035-47. PubMed ID: 25736915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial.
    Chakraborty B; Ghosh P; Moodie EE; Rush AJ
    Biometrics; 2016 Sep; 72(3):865-76. PubMed ID: 26890628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models.
    VanderWeele TJ; Vansteelandt S
    Am J Epidemiol; 2011 Nov; 174(10):1197-203. PubMed ID: 22058231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterfactual clinical prediction models could help to infer individualized treatment effects in randomized controlled trials-An illustration with the International Stroke Trial.
    Nguyen TL; Collins GS; Landais P; Le Manach Y
    J Clin Epidemiol; 2020 Sep; 125():47-56. PubMed ID: 32464321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Random forests of interaction trees for estimating individualized treatment effects in randomized trials.
    Su X; Peña AT; Liu L; Levine RA
    Stat Med; 2018 Jul; 37(17):2547-2560. PubMed ID: 29707855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable selection in regression-based estimation of dynamic treatment regimes.
    Bian Z; Moodie EEM; Shortreed SM; Bhatnagar S
    Biometrics; 2023 Jun; 79(2):988-999. PubMed ID: 34837380
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.